Interactions with David Goldstein, A New Center Leader at Duke s IGSP | GenomeWeb

At A Glance

Name: David Goldstein

Title: Professor of Genetics — Department of Molecular Genetics and Microbiology, Duke University; Director of the Center for Population Genomics and Pharmacogenetics — Institute for Genome Sciences & Policy, Duke University

Background: Wolfson Professor of Genetics — Galton Laboratory in the Department of Biology — University College, London — 1999-2005

Education: PhD in Biological Sciences — Stanford University — 1994

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.